Active

PENIJULLINE

Switched

BE0692832297

Rechtspersoon Private limited company 1 establishment

Oude Kortrijkstraat 30, 8980 Zonnebeke Activiteiten van medisch specialisten

Active for

8 year, 5 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 788,425

▲ 8% vs 2024

Profit

Healthy

€ 585,567

▼ 5% vs 2024

Debts

High

€ 1.2 million

▲ 151% vs 2024

PENIJULLINE from Zonnebeke, company number BE0692832297, closed financial year 2025 with a result of € 585,567 after tax. For that financial year PENIJULLINE recorded a gross margin of € 788,425 and equity of € 18,550. Compared with financial year 2024, the result moved from € 619,352 to € 585,567. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What happened at PENIJULLINE?

What happened at PENIJULLINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 585,567 (▼ 5% vs 2024). Source: NBB ↗
  • New establishment in Zonnebeke. KBO
  • Start of the company according to the CBE. KBO

In short

From € 451,728 profit in 2021 to € 585,567 profit in 2025.

Paid € 831,689 in corporate taxes since 2021.

Best year ever: 2024, with € 619,352 profit.

Paid out € 3.7 million in dividends to the owners in total.

A new publication or filing at PENIJULLINE? We notify you, reason included.

Follow PENIJULLINE

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Francis DUYCK
PENIJULLINE

Behind PENIJULLINE is Francis DUYCK. It owns 25% of Hashimoto BV itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Francis DUYCK

Director

Also active at: HASHIMOTO, Addison

Establishments

Establishment units

Physical locations of this company

Registered office

Oude Kortrijkstraat 30

8980 Zonnebeke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0692.832.297
VAT number
BE 0692.832.297
Registered office
Oude Kortrijkstraat 30, 8980 Zonnebeke
Names & denominations
PENIJULLINE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
22 March 2018
Peppol
Active · Active since 17 Jul 2026
Activities · NACE

Activiteiten van medisch specialisten

Overige zakelijke dienstverlening, neg

Frequently asked questions

What is the enterprise number of PENIJULLINE?
The enterprise number of PENIJULLINE is BE0692832297.
What is the address of PENIJULLINE?
The registered office of PENIJULLINE is located at Oude Kortrijkstraat 30, 8980 Zonnebeke.
When was PENIJULLINE founded?
PENIJULLINE was founded on 22 March 2018.
What is the main activity of PENIJULLINE?
The main activity of PENIJULLINE is "Activiteiten van medisch specialisten" (NACE code 86220).
Does PENIJULLINE have a website?
No website is currently known for PENIJULLINE.
How much profit did PENIJULLINE make in 2025?
PENIJULLINE posted a profit after taxes of € 585,567 in financial year 2025.
What is the revenue of PENIJULLINE?
As a small company, PENIJULLINE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 788,425.
Where can I find the annual accounts of PENIJULLINE?
PENIJULLINE files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of PENIJULLINE?
According to the 2025 annual accounts, the directors of PENIJULLINE are: Francis DUYCK.
Who owns PENIJULLINE?
Behind PENIJULLINE is Francis DUYCK. It owns 25% of Hashimoto BV itself.